Back

Timing of anticoagulation therapy resumption among non-valvular atrial fibrillation (NVAF) patients with prior intracranial haemorrhage

30 August 2026 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Anticoagulation in atrial fibrillation: safety and outcomes Oral Anticoagulation ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Wen Sun

The Chinese University of Hong Kong, Shatin (Hong Kong)

6 More presentations in this session

Presentation thumbnail
Atrial fibrillation and frailty related variance in anticoagulation administration among patients with suspected ischaemic heart disease: the AFRAAID, SWEDEHEART study
Doctor S. Ingves (Norrkoping, SE)
Abstract Slides Video
Presentation thumbnail
Anticoagulation strategies and clinical outcomes in atrial fibrillation patients developing renal deterioration during DOAC therapy
Doctor T. Chao (Taipei, TW)
Abstract Slides Video
Presentation thumbnail
Net clinical benefit of continued oral anticoagulants after successful AF ablation: a nationwide cohort study
Doctor B. Joung (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
D-dimer: a less invasive way to rule out left atrial thrombus
Doctor S. Taerahkun (Bangkok, TH)
Abstract Slides Video
Presentation thumbnail
Anemia and thrombocytopenia in patients with atrial fibrillation: a nationwide study.
Doctor M. Heikkinen (Helsinki, FI)
Abstract Slides Video

Access the full session

Session thumbnail
Anticoagulation in atrial fibrillation: safety and outcomes

The Event

Event poster

ESC Congress 2026

30 August 2026 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Should we initiate oral anticoagulants for patients with atrial fibrillation staying well without oral anticoagulants for years?
28 August 2022
thumbnail
Congress Presentation
Restarting anticoagulation after chronic subdural hematoma neurosurgical evacuation: a prospective observationaL
25 August 2023
thumbnail
Congress Presentation
Impact of left atrial appendage closure on events after intracranial haemorrhage in anticoagulated patients with atrial fibrillation: real life data from the PERSEO registry
1 September 2025
thumbnail
Congress Presentation
Comparative characteristics of anticoagulants used in cancer-associated thrombosis
20 June 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources